• Home
  • Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

About Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

Founded in 2013, Heron Pharma is a pharmaceutical company adhering to an innovation-driven and product differentiation strategy. lt possesses world-leading research and development technology for active vitamin D derivatives, NCEs and first generics. The bulk production of active vitamin D derivative drugs can be provided over the world, including Alfacalcidol, Calcipotriol, Calcifediol, Calcitriol, Eldecalcitol, Doxercalciferol, Maxacalcitol, Paricalcitol, Tacalcitol, etc.

Over the past decade, 8 FDFs have been successfully commercialized in China, including the ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2019
    On CPHI since
  • 1 - 24
    Employees
Company types
Distributor/Import Export
View company profile
Contact info
  • +86 150 2187 4276
  • Website
  • Room 1903, Building 20, No. 1679 Yuqiao Road, Pudong New Area District,, 201204, Shangai, China
Show contact info Hide contact info
Meet us at

CPHI & PMEC China 2025

Shanghai New International Expo Center
24 Jun 2025 - 26 Jun 2025
View Exhibitor Profile

Products from Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd. (9)

  • Calcifediol

    Product Calcifediol

    in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia.
  • Maxacalcitol

    Product Maxacalcitol

    produced under GMP conditions, indicated for Secondary hyperparathyroidism and Psoriasis
  • Calcitriol

    Product Calcitriol

    Calcitriol (骨化三醇)  in compliance with BP/USP/EP monographs, produced under GMP conditions, indicated for Rickets, Osteoporosis, Hypoparathyroidism, Renal osteodystrophy and Osteomalacia.
  • Alfacalcidol

    Product Alfacalcidol

    Alfacalcidol (阿法骨化醇) is in compliance with the monographs of EP/BP/ChP Grade, produced under GMP conditions and indicated for Osteoporosis, Chronic renal insufficiency, Hypoparathyroidism, Vitamin D-resistant rickets and Osteomalacia.
  • Calcipotriol monohydrate

    Product Calcipotriol monohydrate

    EP/BP Grade, produced under GMP conditions, indicated for Psoriasis Vulgaris.
  • Doxercalciferol

    Product Doxercalciferol

    in compliance with Monograph of USP, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Eldecalcitol

    Product Eldecalcitol

    Produced under GMP conditions, indicated for Osteoporosis
  • Paricalcitol

    Product Paricalcitol

     USP grade, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Tacalcitol Monohydrate

    Product Tacalcitol Monohydrate

    in compliance with the monographs of EP/JP, produced under GMP conditions and indicated for Psoriasis Vulgaris

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd. Resources (3)

Recently Visited